A drug with the SMILES CC1Nc2ncnc(N3CCc4ccccc4C3)c2N(Cc2ccc(Br)cc2)C1=O.O=C(O)C(F)(F)F has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 13.806\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CC1Nc2ncnc(N3CCc4ccccc4C3)c2N(Cc2ccc(Br)cc2)C1=O.O=C(O)C(F)(F)F
CC1Nc2ncnc(N3CCc4ccccc4C3)c2N(Cc2ccc(Br)cc2)C1=O.O=C(O)C(F)(F)F
5-[(4-bromophenyl)methyl]-4-(3,4-dihydro-1H-isoquinolin-2-yl)-7-methyl-7,8-dihydropteridin-6-one;2,2,2-trifluoroacetic acid